human thp1 cells Search Results


90
Angio-Proteomie thp 1 cells expressing gfp
( A ) In vitro engineered human blood vessels generated via coculture of HAMEC-dTom and MSCs on Gelfoam constructs. Vessel formation was visualized via live cell confocal imaging after 3 days, before addition of <t>THP-1–derived</t> M0, M1, or M2a macrophages. Changes in network morphology were observed 1 to 3 days after macrophage seeding via confocal microscopy. ( B ) Representative maximum-intensity projections of M0-, M1-, and M2a-seeded vessel networks illustrating interactions between macrophages (green) and vessels (red) 1 day after macrophage seeding. Scale bars, 50 μm. ( C ) Quantification of changes in network morphology via MATLAB analysis in 3D, in terms of the total number of vessels, total vessel length, and total number of branch points (junctions between two vessels). All data were normalized to day 3 baseline measurements and represent means ± SD, n = 3. Two-way ANOVA with Tukey’s post hoc analysis; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001, and # indicates P < 0.05 relative to the M0 control. Data are representative of two independent experiments. ( D ) Representative maximum-intensity projections of engineered vascular grafts that were fixed and stained for the tip cell marker KDR (VEGFR2) via whole-mount immunohistochemistry. Scale bars, 100 μm, n = 3. Vessels shown in red; VEGFR2 staining shown in cyan. ( E ) Quantification of EC VEGFR2 staining, performed on maximum-intensity projections of 2 × 2 tile scans. Pixels colocalized with dTom and VEGFR2 expression were measured and normalized to the total number of dTom+ pixels in each image. Data represent means ± SEM, with n = 4 to 5. One-way ANOVA with Tukey’s post hoc analysis; * P < 0.05 and ** P < 0.01.
Thp 1 Cells Expressing Gfp, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/GFP+Expressing+Human+THP-1+Cells/pmc07195167-179-3-11
Average 90 stars, based on 1 article reviews
thp 1 cells expressing gfp - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Institute for Clinical Pharmacodynamics human leukemia monocytic thp1 cells
( A ) In vitro engineered human blood vessels generated via coculture of HAMEC-dTom and MSCs on Gelfoam constructs. Vessel formation was visualized via live cell confocal imaging after 3 days, before addition of <t>THP-1–derived</t> M0, M1, or M2a macrophages. Changes in network morphology were observed 1 to 3 days after macrophage seeding via confocal microscopy. ( B ) Representative maximum-intensity projections of M0-, M1-, and M2a-seeded vessel networks illustrating interactions between macrophages (green) and vessels (red) 1 day after macrophage seeding. Scale bars, 50 μm. ( C ) Quantification of changes in network morphology via MATLAB analysis in 3D, in terms of the total number of vessels, total vessel length, and total number of branch points (junctions between two vessels). All data were normalized to day 3 baseline measurements and represent means ± SD, n = 3. Two-way ANOVA with Tukey’s post hoc analysis; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001, and # indicates P < 0.05 relative to the M0 control. Data are representative of two independent experiments. ( D ) Representative maximum-intensity projections of engineered vascular grafts that were fixed and stained for the tip cell marker KDR (VEGFR2) via whole-mount immunohistochemistry. Scale bars, 100 μm, n = 3. Vessels shown in red; VEGFR2 staining shown in cyan. ( E ) Quantification of EC VEGFR2 staining, performed on maximum-intensity projections of 2 × 2 tile scans. Pixels colocalized with dTom and VEGFR2 expression were measured and normalized to the total number of dTom+ pixels in each image. Data represent means ± SEM, with n = 4 to 5. One-way ANOVA with Tukey’s post hoc analysis; * P < 0.05 and ** P < 0.01.
Human Leukemia Monocytic Thp1 Cells, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/human+leukemia+monocytic+thp+1+cells/pm35973342-268-0-16
Average 90 stars, based on 1 article reviews
human leukemia monocytic thp1 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
FUJIFILM thp-1 human monocytic leukemia cell line
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
Thp 1 Human Monocytic Leukemia Cell Line, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/thp+1+human+monocytic+leukemia+cell+line/pmc05669446-56-1-13
Average 90 stars, based on 1 article reviews
thp-1 human monocytic leukemia cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
AddexBio Inc human monocytic cell line thp-1
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
Human Monocytic Cell Line Thp 1, supplied by AddexBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/human+monocytic+cell+line+thp+1/pmc10314949-283-2-6
Average 90 stars, based on 1 article reviews
human monocytic cell line thp-1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
EuroClone thp-1 cells (human leukemia monocytic cell line)
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
Thp 1 Cells (Human Leukemia Monocytic Cell Line), supplied by EuroClone, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/thp+1+cells++human+leukemia+monocytic+cell+line+/pm29758517-387-0-15
Average 90 stars, based on 1 article reviews
thp-1 cells (human leukemia monocytic cell line) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
China Pharmaceuticals Inc monocyte-macrophage thp-1
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
Monocyte Macrophage Thp 1, supplied by China Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/human+monocyte+line+thp+1+cells/pmc07294121-32-1-6
Average 90 stars, based on 1 article reviews
monocyte-macrophage thp-1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dainippon Sumitomo u937 monocytic leukemia cell line
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
U937 Monocytic Leukemia Cell Line, supplied by Dainippon Sumitomo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/human+thp+1+monocytic+leukemia+cell+line/pm25310083-22-1-7
Average 90 stars, based on 1 article reviews
u937 monocytic leukemia cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas thp-1 cells
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
Thp 1 Cells, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/thp+1+cells/pm34649616-84-12-17
Average 90 stars, based on 1 article reviews
thp-1 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biowhittaker Inc human monocytic thp-1 cells
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
Human Monocytic Thp 1 Cells, supplied by Biowhittaker Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/human+monocytic+thp+1+cells/pmc02739727-328-0-8
Average 90 stars, based on 1 article reviews
human monocytic thp-1 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Access Business Group LLC thp-1 human monocyte cell line
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
Thp 1 Human Monocyte Cell Line, supplied by Access Business Group LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/thp+1+human+monocyte+cell+line/pmc08320399-74-22-8
Average 90 stars, based on 1 article reviews
thp-1 human monocyte cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics fluorescently labeled thp-1 monocytes
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
Fluorescently Labeled Thp 1 Monocytes, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/thp+1+human+monocytic+cells/pmc06118158-55-25-9
Average 90 stars, based on 1 article reviews
fluorescently labeled thp-1 monocytes - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biotechnology Information human acute monocytic leukemia cell line thp-1
(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated <t>THP-1</t> cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.
Human Acute Monocytic Leukemia Cell Line Thp 1, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+thp1+cells/thp1+human+derived+monocytic+cell+line/pmc08201858-19-11-40
Average 90 stars, based on 1 article reviews
human acute monocytic leukemia cell line thp-1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


( A ) In vitro engineered human blood vessels generated via coculture of HAMEC-dTom and MSCs on Gelfoam constructs. Vessel formation was visualized via live cell confocal imaging after 3 days, before addition of THP-1–derived M0, M1, or M2a macrophages. Changes in network morphology were observed 1 to 3 days after macrophage seeding via confocal microscopy. ( B ) Representative maximum-intensity projections of M0-, M1-, and M2a-seeded vessel networks illustrating interactions between macrophages (green) and vessels (red) 1 day after macrophage seeding. Scale bars, 50 μm. ( C ) Quantification of changes in network morphology via MATLAB analysis in 3D, in terms of the total number of vessels, total vessel length, and total number of branch points (junctions between two vessels). All data were normalized to day 3 baseline measurements and represent means ± SD, n = 3. Two-way ANOVA with Tukey’s post hoc analysis; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001, and # indicates P < 0.05 relative to the M0 control. Data are representative of two independent experiments. ( D ) Representative maximum-intensity projections of engineered vascular grafts that were fixed and stained for the tip cell marker KDR (VEGFR2) via whole-mount immunohistochemistry. Scale bars, 100 μm, n = 3. Vessels shown in red; VEGFR2 staining shown in cyan. ( E ) Quantification of EC VEGFR2 staining, performed on maximum-intensity projections of 2 × 2 tile scans. Pixels colocalized with dTom and VEGFR2 expression were measured and normalized to the total number of dTom+ pixels in each image. Data represent means ± SEM, with n = 4 to 5. One-way ANOVA with Tukey’s post hoc analysis; * P < 0.05 and ** P < 0.01.

Journal: Science Advances

Article Title: Macrophages of diverse phenotypes drive vascularization of engineered tissues

doi: 10.1126/sciadv.aay6391

Figure Lengend Snippet: ( A ) In vitro engineered human blood vessels generated via coculture of HAMEC-dTom and MSCs on Gelfoam constructs. Vessel formation was visualized via live cell confocal imaging after 3 days, before addition of THP-1–derived M0, M1, or M2a macrophages. Changes in network morphology were observed 1 to 3 days after macrophage seeding via confocal microscopy. ( B ) Representative maximum-intensity projections of M0-, M1-, and M2a-seeded vessel networks illustrating interactions between macrophages (green) and vessels (red) 1 day after macrophage seeding. Scale bars, 50 μm. ( C ) Quantification of changes in network morphology via MATLAB analysis in 3D, in terms of the total number of vessels, total vessel length, and total number of branch points (junctions between two vessels). All data were normalized to day 3 baseline measurements and represent means ± SD, n = 3. Two-way ANOVA with Tukey’s post hoc analysis; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001, and # indicates P < 0.05 relative to the M0 control. Data are representative of two independent experiments. ( D ) Representative maximum-intensity projections of engineered vascular grafts that were fixed and stained for the tip cell marker KDR (VEGFR2) via whole-mount immunohistochemistry. Scale bars, 100 μm, n = 3. Vessels shown in red; VEGFR2 staining shown in cyan. ( E ) Quantification of EC VEGFR2 staining, performed on maximum-intensity projections of 2 × 2 tile scans. Pixels colocalized with dTom and VEGFR2 expression were measured and normalized to the total number of dTom+ pixels in each image. Data represent means ± SEM, with n = 4 to 5. One-way ANOVA with Tukey’s post hoc analysis; * P < 0.05 and ** P < 0.01.

Article Snippet: To visualize macrophages, THP-1 cells expressing GFP (GFP–THP-1) were purchased from Angio-Proteomie (Boston, MA).

Techniques: In Vitro, Generated, Construct, Confocal, Imaging, Derivative Assay, Morphology, Microscopy, Analysis, Control, Staining, Marker, Immunohistochemistry, Expressing

(A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated THP-1 cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.

Journal: Biochemistry and Biophysics Reports

Article Title: Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-κB signaling pathways

doi: 10.1016/j.bbrep.2015.11.003

Figure Lengend Snippet: (A) Time-dependent changes in cytokine and chemokine production in LPS-stimulated THP-1 cells. After LPS (10 μg/ml) treatment for 15, 30, 60, or 120 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 μg/ml), cytokines and chemokines were measured using Multi Plex according to the manufacturer’s protocols. * p <0.05 compared with LPS only at 60 min. ** p <0.05 compared with LPS only at 120 min. Mino: minocycline, Tige: tigecycline, Doxy: doxycycline. (B) The rate of cytokine and chemokine production in the THP-1 cell line compared to the production of cytokines and chemokines by LPS stimulation without tetracyclines. After LPS treatment (10 μg/ml) for 30, 60, 120 or 240 min without any agents and with minocycline (50 μg/ml), tigecycline (50 μg/ml), or doxycycline (50 mg/ml), cytokines and chemokines were measured with Multi Plex.

Article Snippet: The THP-1 human monocytic leukemia cell line was purchased from RIKEN Cell Bank (Wako, Japan).

Techniques:

Effects of minocycline, doxycycline, and tigecycline on the modulation of NF-κB, phospho-NF-κB, IKKα/β, phospho-IKKα/β, IκBα, and phospho-IκBα in LPS-stimulated THP-1 cells. THP-1 cells were incubated without or with 10 μg/ml LPS, or with LPS plus minocycline (50 μg/ml), doxycycline (50 μg/ml), or tigecycline (50 μg/ml) for 30, 60, or 120 min. NF-κB, phospho-NF-κB, IKKα/β, phospho-IKKα/β, IκBα, and phospho-IκBα were assessed with Western blotting.

Journal: Biochemistry and Biophysics Reports

Article Title: Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-κB signaling pathways

doi: 10.1016/j.bbrep.2015.11.003

Figure Lengend Snippet: Effects of minocycline, doxycycline, and tigecycline on the modulation of NF-κB, phospho-NF-κB, IKKα/β, phospho-IKKα/β, IκBα, and phospho-IκBα in LPS-stimulated THP-1 cells. THP-1 cells were incubated without or with 10 μg/ml LPS, or with LPS plus minocycline (50 μg/ml), doxycycline (50 μg/ml), or tigecycline (50 μg/ml) for 30, 60, or 120 min. NF-κB, phospho-NF-κB, IKKα/β, phospho-IKKα/β, IκBα, and phospho-IκBα were assessed with Western blotting.

Article Snippet: The THP-1 human monocytic leukemia cell line was purchased from RIKEN Cell Bank (Wako, Japan).

Techniques: Incubation, Western Blot

Effects of tetracyclines (minocycline, doxycycline, and tigecycline) on the activation of phospho-ERK1/2 and phospho-p38 in LPS-stimulated THP-1 cells. THP-1 cells were incubated without or with 10 μg/ml LPS, or with LPS plus minocycline (50 μg/ml), doxycycline (50 μg/ml), or tigecycline (50 μg/ml) for 30 or 60 min. Phospho-p38 and phospho-ERK1/2 were assessed with Western blotting.

Journal: Biochemistry and Biophysics Reports

Article Title: Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-κB signaling pathways

doi: 10.1016/j.bbrep.2015.11.003

Figure Lengend Snippet: Effects of tetracyclines (minocycline, doxycycline, and tigecycline) on the activation of phospho-ERK1/2 and phospho-p38 in LPS-stimulated THP-1 cells. THP-1 cells were incubated without or with 10 μg/ml LPS, or with LPS plus minocycline (50 μg/ml), doxycycline (50 μg/ml), or tigecycline (50 μg/ml) for 30 or 60 min. Phospho-p38 and phospho-ERK1/2 were assessed with Western blotting.

Article Snippet: The THP-1 human monocytic leukemia cell line was purchased from RIKEN Cell Bank (Wako, Japan).

Techniques: Activation Assay, Incubation, Western Blot

SB203580, U0126 and BAY11-7082 suppressed TNF-α and IL-8 production in LPS-stimulated THP-1 cells on treatment with or without tetracyclines. THP-1 cells were pre-incubated by SB203580 (10 μM), U0126 (5 μM) and BAY11-7082 (5 μM) for 30 min, followed treatment without or with LPS (10 μg/ml), or with LPS (10 μg/ml) plus minocycline (50 μg/ml), doxycycline (50 μg/ml), or tigecycline (50 μg/ml) for 60 min. TNF-α were measured with ELISA. * p <0.05, ** p <0.01, *** p <0.001 compared to the measurement without the inhibitor in the same group. Abbreviation; SB: SB203580, U: U0126, BAY: BAY11-7082.

Journal: Biochemistry and Biophysics Reports

Article Title: Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-κB signaling pathways

doi: 10.1016/j.bbrep.2015.11.003

Figure Lengend Snippet: SB203580, U0126 and BAY11-7082 suppressed TNF-α and IL-8 production in LPS-stimulated THP-1 cells on treatment with or without tetracyclines. THP-1 cells were pre-incubated by SB203580 (10 μM), U0126 (5 μM) and BAY11-7082 (5 μM) for 30 min, followed treatment without or with LPS (10 μg/ml), or with LPS (10 μg/ml) plus minocycline (50 μg/ml), doxycycline (50 μg/ml), or tigecycline (50 μg/ml) for 60 min. TNF-α were measured with ELISA. * p <0.05, ** p <0.01, *** p <0.001 compared to the measurement without the inhibitor in the same group. Abbreviation; SB: SB203580, U: U0126, BAY: BAY11-7082.

Article Snippet: The THP-1 human monocytic leukemia cell line was purchased from RIKEN Cell Bank (Wako, Japan).

Techniques: Incubation, Enzyme-linked Immunosorbent Assay